Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 659 recruiting now near national open share early-phase tilt

Clinical trials in Wisconsin

659 of 1,760 in-state trials are recruiting (37%); roughly in line with the 37% national average, with Phase 2 weight.

According to ClinicalTrials.gov-derived indexes, Wisconsin sits in the lower half of US states by in-state trial count (#30 of 52 states by registered in-state trial count).

Wisconsin: 1,760 US clinical trials with in-state sites, 659 recruiting.

Wisconsin has 1,760 registered US clinical trials with a study site in-state, 659 of them currently recruiting (roughly in line with the 37% national average). 187 of these trials are in Phase 3 (late-stage) and 403 in Phase 2. The most frequently studied condition in Wisconsin is Healthy, with 45 linked trials.

Lower-half Wisconsin archive

Wisconsin's in-state trials target 53,462 patients on average (p100 by trial size among 52 states with enrollment data), larger, multi-site studies than most states. Treat this page as a compact local index (mid-volume · high-open), then jump to recruiting trials or methodology rather than expecting hub-scale coverage.

In-line with national open share

Wisconsin tracks 1,760 in-state trials with 659 open (37%), roughly in line with the 37% national average within about 1-2 points of the 37% national figure.

37%
open (near national share)
659
recruiting participants now
187
Phase 3 (late-stage)
45
top: Healthy

Recruiting share is roughly in line with the 37% national average. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.

Wisconsin vs all states by indexed in-state trial count

Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)

1,760 Top 58% more indexed trials than 42% of 52 states

States, banded by indexed in-state trial count

Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov · 2026-08-08

Key findings

What ClinicalTrials.gov does not surface for Wisconsin on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Wisconsin open-enrollment share matches the national baseline.

    659 of 1,760 in-state trials (37.4%) are recruiting, against 37% nationally (+0.4 percentage points). Counts include every study with at least one recorded site in the state.

  2. Wisconsin trial sites spread across 8 city hubs.

    Madison lists 867 of 1,760 in-state trials (49.3%) across 277 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.

  3. Healthy is the most-studied condition in Wisconsin.

    45 of 1,760 in-state trials (2.6%) list Healthy. That is a local concentration figure, not a national disease ranking.

  4. One sponsor accounts for a large share of Wisconsin trials.

    University of Wisconsin, Madison appears on 338 of 1,760 in-state trials (19.2%). Sponsor identity is as filed on ClinicalTrials.gov.

  5. 730 Wisconsin trials carry a completed status.

    730 of 1,760 (41.5%) are completed. The open share above is the remainder that still lists recruiting.

Completed730Recruiting659Active371
NA442Phase 2403Phase 1381Phase 3187Phase 471Early Phase 116

By Status

StatusTrial count
Completed 730
Recruiting 659
Active 371

By Phase

PhaseTrial count
NA 442
Phase 2 403
Phase 1 381
Phase 3 187
Phase 4 71
Early Phase 1 16

Where trials run in Wisconsin

Madison carries 867 of Wisconsin's 1,760 indexed trials (49%) across 277 named sites, ahead of Milwaukee at 719. 8 cities clear five listed trials, together naming 584 distinct sites.

City Trials Listed sites
Madison 867 277
Milwaukee 719 226
La Crosse 40 19
Wauwatosa 29 20
Marshfield 28 11
Eau Claire 23 9
West Bend 19 7
Green Bay 17 15

Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.

Trial size large

Wisconsin's in-state trials target 53,462 patients on average (p100 by trial size among 52 states with enrollment data), larger, multi-site studies than most states.

Wisconsin: in-state trial volume sits mid-pack

Sites spread across 8 cities with five or more listed trials, led by Madison (867, 49% of the state total) and Milwaukee (719), together naming 584 distinct research locations.

Phase mix: 187 Phase 3 vs 403 Phase 2 (early-phase heavy).

Top condition: Healthy (45 trials); top sponsor University of Wisconsin, Madison (338).

mid-volume · high-open figures (1,760 trials · 37% open) describe registry geography under the trial size large read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.

States near Wisconsin on in-state trial volume

Cross-state peers under the trial size large read (mid-volume · high-open), not the same-state browse list.

Similar mid-volume peers (± open share)

  • South Carolina · 1,706 trials · 35% recruiting
  • Louisiana · 1,936 trials · 28% recruiting
  • Iowa · 1,544 trials · 33% recruiting
  • Oregon · 1,999 trials · 34% recruiting
  • Kansas · 2,080 trials · 29% recruiting

Similar high-open peers (± trial volume)

Source: ClinicalTrials.gov, the US trial registry maintained by the National Library of Medicine, part of the NIH. Wisconsin series (mid-volume · high-open · trial size large) retrieved and formatted by PlainTrial, see methodology.